Bigtime losses, but cash still flows in
Its a poorly kept secret: Biotechs rarely make money. But their potential keeps investment dollars flowing.
Biotechnology proponents rarely talk about the fact that the industry loses huge quantities of money. According to a new report from accountants Ernst & Young, the public biotechnology companies in New England collectively lost $1.3 billion in 2006, the highest loss of any region in the country. (Full article: 921 words)
This article is available in our archives:
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass